Utilizing Leptotrichia-derived Cas13a proteins and optimized crRNAs demonstrated robust knockdown of KRAS-G12D mRNA, inhibiting downstream signaling pathways and impeding tumor growth in vivo [91]. This evidence concerns the gene KRAS and neoplasm.